| 1 |
A Study on Verification of Equivalence and Effectiveness of Non-Pharmacologic Dementia Prevention and Early Detection Contents : Non-Randomly Equivalent Design |
|
|
| Hyun-Seok Jeong, Oh-Lyong Kim, Bon-Hoon Koo, Ki-Hyun Kim, Gi-Hwan Kim, Dai-Seg Bai, Ji-Yean Kim, Mun-Seon Chang, Hye-Geum Kim |
|
| Journal of Korean Neurosurgical Society. 2022; 65(2): 315 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Digital Twins for Multiple Sclerosis |
|
|
| Isabel Voigt,Hernan Inojosa,Anja Dillenseger,Rocco Haase,Katja Akgün,Tjalf Ziemssen |
|
| Frontiers in Immunology. 2021; 12 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Standardization and digitization of clinical data in multiple sclerosis |
|
|
| Marcus D’Souza,Athina Papadopoulou,Christophe Girardey,Ludwig Kappos |
|
| Nature Reviews Neurology. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
The challenges of implementing the Clinical data standards |
|
|
| Deepak K. Tempe,Praveen K. Neema |
|
| Journal of Cardiothoracic and Vascular Anesthesia. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Machine Learning in Drug Discovery and Development Part 1: A Primer |
|
|
| Alan Talevi,Juan Francisco Morales,Gregory Hather,Jagdeep T. Podichetty,Sarah Kim,Peter C. Bloomingdale,Samuel Kim,Jackson Burton,Joshua D. Brown,Almut G. Winterstein,Stephan Schmidt,Jensen Kael White,Daniela J. Conrado |
|
| CPT: Pharmacometrics & Systems Pharmacology. 2020; 9(3): 129 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
The Clinical Liver Safety Assessment Best Practices Workshop: Rationale, Goals, Accomplishments and the Future |
|
|
| Paul B. Watkins,Michael Merz,Mark I. Avigan,Neil Kaplowitz,Arie Regev,John R. Senior |
|
| Drug Safety. 2014; 37(S1): 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
